Yuflyma

Medicinal product

(Invented) name

Yuflyma

Active substance (s)

Adalimumabas

Strength

40 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AB04, Adalimumab

Marketing authorisation holder

Abacus Medicine A/S, Danija

Date of authorisation

2025-02-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

CR-Lygiagretus platinimas

Qualitative and quantitative composition

Solution for injection in pre-filled pen	1 vnt.
Adalimumabas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117957	104062	1104062	užpildytas švirkštiklis	2 pre-filled pens + 2 alcohol pads		Receptinis	EU/1/20/1513/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-02-21	Registruotas